Skip to content

Advertisement

  • Poster presentation
  • Open Access

High-dose dobutamine stress magnetic resonance perfusion imaging at 3.0 Tesla

  • 1,
  • 1,
  • 1,
  • 1,
  • 2,
  • 1,
  • 1 and
  • 1
Journal of Cardiovascular Magnetic Resonance201315 (Suppl 1) :P211

https://doi.org/10.1186/1532-429X-15-S1-P211

  • Published:

Keywords

  • Dobutamine
  • Wall Motion Abnormality
  • Steady State Free Precession
  • Magnetic Resonance Perfusion Imaging
  • Steady State Free Precession Sequence

Background

Dobutamine stress magnetic resonance (DSMR-wall motion) has been established as a valuable tool for the detection of inducible wall motion abnormalities. Additional perfusion imaging during DSMR (DSMR-perfusion) was shown to improve sensitivity for the detection of myocardial ischemia. Current experience is based on 1.5T only, mainly due to insufficient image quality of steady state free precession (SSFP) cine imaging at higher field strengths. Recently, image quality and diagnostic accuracy of SSFP sequences was significantly improved by dual-source parallel radiofrequency (RF) transmission for 3.0T. We examined whether the addition of myocardial perfusion imaging during DSMR at 3.0T is feasible and whether it provides incremental benefit for the evaluation of CAD.

Methods

DSMR-wall motion and -perfusion were combined in 48 consecutive patients on 3.0T clinical systems (Philips Achieva and Ingenia, both equipped with a dual-source RF transmission system) applying a standard high dose dobutamine-atropine protocol. Perfusion images were acquired in three short axis views during maximum stress. Wall motion and perfusion images were interpreted sequentially by two blinded readers with invasive coronary angiography serving as the reference standard.

Results

Assessment of wall motion and perfusion at rest and during stress were feasible in 98% of patients. One patient (2%) developed atrial fibrillation during dobutamine infusion and the examination had to be terminated. Two patients (4%) developed wall motion abnormalities before reaching target heart rate and DSMR-perfusion was performed at this time. Mean dobutamine dose was 32±8 µg/kg/min, atropine was given in 28 (58%) patients. Interobserver agreement was very good for DSMR-wall motion (κ 0.88) and -perfusion (κ 0.83). The prevalence of CAD (>70% stenosis) was 64% and involved 45 coronary territories. On a patient basis, diagnostic accuracy of DSMR-wall motion and DSMR-perfusion were similar (Table). DSMR-wall motion correctly identified 28 (62%) territories supplied by a stenotic coronary artery, whereas DSMR-perfusion correctly identified significantly more ischemic territories (n=38, 84%, P<0.002). The ability to recognize a patient as having multivessel disease by more than one territory demonstrating an ischemic reaction was improved significantly by use of DSMR-perfusion (91% vs. 36%, p=0.03, Figure).
Table 1

Diagnostic accuracy of DSMR-wall motion and DSMR-perfusion

 

Sensitivity

Specificity

Accuracy

Coronary stenosis ≥50%

DSMR-wall motion

DSMR-perfusion

P

DSMR-wall motion

DSMR-perfusion

P

DSMR-wall motion

DSMR-perfusion

P

All patients

27/36 (75)

30/36 (83)

0.25

10/11 (91)

10/11 (91)

1

37/47 (79)

40/47 (85)

0.38

Coronary stenosis ≥70%

         

All patients

26/30 (87)

28/30 (93)

0.5

15/17 (88)

14/17 (82)

1

41/47 (87)

42/47 (89)

0.38

values are n (%), P indicates the significance level for differences between DSMR-wall motion and DSMR-perfusion

Figure 1
Figure 1

Patient with stenoses of the LAD- and RCA-territory showing false-negative DSMR-wall motion and true-positive DSMR-perfusion (white arrows), ED=end diastolic, ES=end systolic

Conclusions

DSMR-perfusion is feasible with a high procedural success rate at 3.0T applying dual-source RF transmission and has additional diagnostic value compared to DSMR-wall motion regarding the extent of stress inducible ischemia.

Funding

none

Authors’ Affiliations

(1)
German Heart Institute Berlin, Berlin, Germany
(2)
Philips Health Care, Hamburg, Germany

Copyright

© Gebker et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement